2762. Activity of Cefiderocol and Comparator Agents Against Difficult to Treat Resistance (DTR) Gram-negative Isolates, Collected During 2020-2022 as Part of SENTRY Antimicrobial Surveillance Program

BACKGROUND: Difficult to Treat Resistant (DTR) Gram-negative isolates show treatment-limiting resistance to all first-line agents; β-lactams and fluoroquinolones. Cefiderocol (CFDC) is a siderophore-conjugated cephalosporin with a unique mode of entry into bacteria, showing good activity against Gra...

Descripción completa

Detalles Bibliográficos
Autores principales: DeJonge, Boudewijn L, Nguyen, Sean T, Bryowsky, Jason J, Longshaw, Christopher M, Maher, Joshua, Mendes, Rodrigo E, Takemura, Miki, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678551/
http://dx.doi.org/10.1093/ofid/ofad500.2373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678551/
http://dx.doi.org/10.1093/ofid/ofad500.2373

Ejemplares similares